Shareholder Votes

T-Mobile US, Inc. shareholders approved Elect 13 director nominees named in the Proxy Statement to the Company's Board of Directors at the 2026-06-16 meeting.

“Proposal 1 – Election of Directors. The following 13 director nominees were elected as directors, each to hold office until the Company’s 2027 Annual Meeting of Stockholders, or until his/her successor is elected and qualified, by the votes set forth below:”

SOLITARIO RESOURCES CORP. shareholders approved Appointment of Auditors at the 2026-06-17 meeting.

“Appointment of Auditors. The appointment of Assure CPA, LLC, which merged with and was succeded by Sadler, Gibb & Associates effective June 3, 2026, as Solitario’s auditors for fiscal year 2026 was ratified, with 51,036,820 shares voting for (98.70% of shares voting) , 122,148 shares voting against, 548,380 shares voting to abstain.”

SOLITARIO RESOURCES CORP. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-17 meeting.

“Advisory Vote on Executive Compensation: The shareholders approved the following resolution concerning the compensation of Solitario’s named executive officers, with 37,403,628 shares voting for (96.84% of shares voting ), 574,407 shares voting against, 645,555 shares abstaining, and 13,083,756 broker non-votes.”

SOLITARIO RESOURCES CORP. shareholders approved Election of Directors at the 2026-06-17 meeting.

“Six directors were elected to serve until the next annual meeting of shareholders or until their successors are elected and qualified, with each director receiving the votes below: Number of Shares Name For Withheld Broker Non-Votes John Labate 38,367,832 (99.34% of shares voting) 255,761 13,083,756 James Hesketh 34,906,464 (90.38% of shares voting) 3,717,129 13,083,756 Christopher E. Herald 38,436,870 (99.52% of shares voting) 186,723 13,083,756 Gil Atzmon 38,735,431 (99.36% of shares voting) 248,162 13,083,756 Debbie Mino-Austin 37,738,400 (97.71% of shares voting) 885,193 13,083,756”

CHAIN BRIDGE BANCORP INC shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.

“The Company’s stockholders ratified the appointment of Yount, Hyde & Barbour, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

CHAIN BRIDGE BANCORP INC shareholders approved Election of Directors at the 2026-06-17 meeting.

“Each of the thirteen (13) director nominees was elected to serve until the Company’s 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified.”

BLUE RIDGE BANKSHARES, INC. shareholders approved Ratification of appointment of Elliott Davis, PLLC as independent registered public accounting firm for 2026 at the 2026-06-17 meeting.

“Proposal 2: Ratification of Independent Registered Public Accounting Firm for 2026 Shareholders ratified the appointment of Elliott Davis, PLLC as the Company’s independent registered public accounting firm for 2026. For Against Abstain Non-votes 80,371,599 217,271 16,205 0”

CITIZENS, INC. shareholders approved To approve the Company's amended and restated Omnibus Incentive Plan at the 2026-06-16 meeting.

“Proposal 4 – Approval of Amended and Restated Omnibus Incentive Plan For: 8,700,635 98% Against: 94,580 1% Abstain: 92,618 1% Broker Non-Votes: 1,638,768 N/A”

CITIZENS, INC. shareholders approved To approve, on a non-binding advisory basis, executive compensation (“Say-On-Pay”) at the 2026-06-16 meeting.

“Proposal 3 – Approval, on a non-binding advisory basis, of Executive Compensation ("Say-on-Pay") For: 8,766,665 99% Against: 83,841 <1% Abstain: 37,327 <1% Broker Non-Votes: 1,638,768 N/A”

CITIZENS, INC. shareholders approved To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for 2026 at the 2026-06-16 meeting.

“Proposal 2 – Ratification of the Appointment of Grant Thornton LLP as Independent Registered Public Accounting Firm for 2026 For: 10,492,944 99.7% Against: 1,005 <1% Abstain: 32,651 <1% Broker Non-Votes: N/A N/A”

CITIZENS, INC. shareholders approved To elect each of the 7 director nominees identified in the Proxy Statement to the Citizens, Inc. Board of Directors at the 2026-06-16 meeting.

“Proposal 1 – Election of Directors Name For Against Abstain Broker Non-Votes Peter M. Carlson 8,835,113 18,809 33,911 1,638,768 Christopher W. Claus 8,752,863 100,318 34,651 1,638,768 Cynthia H. Davis 8,727,837 124,061 35,935 1,638,768 Michael Harwood 8,842,962 7,989 36,881 1,638,768 Sean McLaughlin 8,849,135 6,648 32,049 1,638,768 Jon Stenberg 8,766,788 49,695 71,349 1,638,768 Mary Taylor 8,738,930 115,266 33,637 1,638,768”

Translational Development Acquisition Corp. shareholders approved Adjournment Proposal to adjourn the Meeting if necessary.

“The Adjournment Proposal was approved with the following vote: For Against Abstentions Broker Non-Votes 16,621,609 809,296 0 0”

Translational Development Acquisition Corp. shareholders approved Trust Agreement Amendment Proposal to amend the Trust Agreement to allow extension of Deadline Date with monthly deposits.

“The Trust Agreement Amendment Proposal was approved with the following vote: For Against Abstentions Broker Non-Votes 16,621,609 809,296 0 0”

Translational Development Acquisition Corp. shareholders approved Extension Amendment Proposal to amend the Existing Charter to extend business combination deadline.

“The Extension Amendment Proposal was approved with the following vote: For Against Abstentions Broker Non-Votes 16,621,609 809,296 0 0”

LM FUNDING AMERICA, INC. shareholders approved Approval of an amendment (in the event it is deemed by the Company’s Board of Directors to be advisable) to the Company’s Certificate of Incorporation, as amended, in the form attached to the proxy statement as Appendix A, to effect a reverse stock split of the Company's issued and outstanding share at the 2026-06-16 meeting.

“Proposal 4: Approval of an amendment (in the event it is deemed by the Company’s Board of Directors to be advisable) to the Company’s Certificate of Incorporation, as amended, in the form attached to the proxy statement as Appendix A, to effect a reverse stock split of the Company's issued and outstanding shares of common stock at an exchange ratio ranging from one-for-five (1:5) to one-for-twentyfive (1:25), with the exact ratio to be determined by the Company's Board of Directors. Votes For Votes Against Votes Abstain Broker Non-Votes 7,335,079 1,695,929 5,693 0”

LM FUNDING AMERICA, INC. shareholders approved Approval in accordance with Nasdaq Listing Rule 5635(d), of the issuance of more than 19.99% of the Company’s outstanding common stock issuable upon the exercise of investor warrants that were issued in a financing transaction in December 2025 and the exercise, at a reduced price, of warrants origin at the 2026-06-16 meeting.

“Proposal 3: Approval in accordance with Nasdaq Listing Rule 5635(d), of the issuance of more than 19.99% of the Company’s outstanding common stock issuable upon the exercise of investor warrants that were issued in a financing transaction in December 2025 and the exercise, at a reduced price, of warrants originally issued in December 2024 The Company’s stockholders approved the issuance of more than 19.99% of the Company’s outstanding common stock issuable upon the exercise of investor warrants that were issued in a financing transaction in December 2025 and the exercise, at a reduced price, of warrants originally issued in December 2024: Votes For Votes Against Withhold/Abstain Broker Non-Votes 2,309,796 1,492,808 9,162 5,224,935”

LM FUNDING AMERICA, INC. shareholders approved Ratification of appointment of MaloneBailey, LLP as the company’s independent auditor to audit the Company’s 2026 financial statements at the 2026-06-16 meeting.

“Proposal 2: Ratification of appointment of MaloneBailey, LLP as the company’s independent auditor to audit the Company’s 2026 financial statements The Company’s stockholders ratified the appointment of MaloneBailey, LLP to serve as the Company’s independent registered accounting firm for fiscal year 2026 by the following final voting results: Votes For Votes Against Withhold/Abstain Broker Non-Votes 8,767,142 182,488 87,071 -”

LM FUNDING AMERICA, INC. shareholders approved Election of directors at the 2026-06-16 meeting.

“Proposal 1: Election of directors The two nominees identified below were elected to serve as Class I directors of the Company to hold office until the third annual meeting of stockholders following their election by the following final voting results: Name Votes For Votes Withheld Broker Non-Votes Bruce Rodgers 3,260,620 551,146 5,224,935 Carollinn Gould 3,146,201 665,565 5,224,935”

BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration policy at the 2026-06-17 meeting.

“Proposal 9 – To approve the directors’ remuneration policy, which policy is set forth in the Company’s definitive proxy statement, and which will take effect immediately after the end of the AGM For Against Vote Withheld/Abstain 48,238,031 1,293,722 165,155”

BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration report for the year ended December 31, 2025 (excluding the remuneration policy) at the 2026-06-17 meeting.

“Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2025, which report is set forth in the Company’s definitive proxy statement (excluding the directors’ remuneration policy) For Against Vote Withheld/Abstain 48,741,517 792,394 162,997”

BICYCLE THERAPEUTICS PLC shareholders approved To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2025 at the 2026-06-17 meeting.

“Proposal 7 – To receive and adopt the Company’s U.K. statutory annual accounts and reports for the year ended December 31, 2025. For Against Vote Withheld/Abstain 49,138,590 553,781 4,537”

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Audit Committee to determine the Company's U.K. statutory auditors' remuneration for the year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 6 – To authorize the Audit Committee of the Company’s Board of Directors to determine the Company’s U.K. statutory auditors’ remuneration for the year ending December 31, 2026 For Against Vote Withheld/Abstain 49,493,240 47,269 156,399”

BICYCLE THERAPEUTICS PLC shareholders approved To re-appoint PricewaterhouseCoopers LLP as the Company's U.K. statutory auditors to hold office until the conclusion of the next annual general meeting at the 2026-06-17 meeting.

“Proposal 5 – To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders For Against Vote Withheld/Abstain 49,441,337 235,008 20,563”

BICYCLE THERAPEUTICS PLC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 4 – To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s independent registered public accounting firm for the year ending December 31, 2026 For Against Vote Withheld/Abstain 49,445,128 232,627 19,153”

BICYCLE THERAPEUTICS PLC shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers at the 2026-06-17 meeting.

“Proposal 3 – To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement For Against Vote Withheld/Abstain 48,748,743 785,032 163,133”

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Hervé Hoppenot at the 2026-06-17 meeting.

“Proposal 2 – To re-elect as a director Hervé Hoppenot For Against Vote Withheld/Abstain 49,284,459 250,669 161,780”

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Felix Baker at the 2026-06-17 meeting.

“Proposal 1 – To re-elect as a director Felix Baker For Against Vote Withheld/Abstain 46,171,302 3,364,113 161,493”

COGNITION THERAPEUTICS INC shareholders approved Ratification of Independent Registered Public Accountants at the 2026-06-17 meeting.

“The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was ratified, as follows: For Against Abstentions Broker Non-Votes 49,039,407 126,951 643,517 0”

COGNITION THERAPEUTICS INC shareholders approved Election of Class II Directors at the 2026-06-17 meeting.

“Each of Aaron Fletcher, Ph.D., and Lisa Ricciardi were elected to the Board of Directors as Class II directors to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal as follows: Name For Withheld Broker Non-Votes Aaron Fletcher, Ph.D. 15,093,537 680,677 34,035,661 Lisa Ricciardi 15,094,238 679,976 34,035,661”

AlTi Global, Inc. shareholders approved To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2026. at the 2026-06-17 meeting.

“Proposal 2 : To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2026. For Against Abstain Broker Non-Votes 93,116,677 740,193 2,291,541 0”

AlTi Global, Inc. shareholders approved To vote to elect as directors the seven nominees named in the Proxy Statement for a term of office expiring at the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified. at the 2026-06-17 meeting.

“Proposal 1 : To vote to elect as directors the seven nominees named in the Proxy Statement for a term of office expiring at the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified. For Withhold Broker Non-Vote Ali Bouzarif 68,208,164 13,188,748 14,751,499 Nazim Cetin 60,758,230 20,638,682 14,751,499 Norma Corio 56,875,518 24,521,394 14,751,499 Nancy Curtin 81,020,789 376,123 14,751,499 Mark Furlong 78,347,853 3,049,059 14,751,499 Timothy Keaney 60,847,928 20,548,984 14,751,499 Andreas Wimmer 72,837,500 8,559,412 14,751,499”

HG Holdings, Inc. shareholders approved Advisory, non-binding approval of compensation paid to named executive officers for the year ended December 31, 2025 at the 2026-06-15 meeting.

“As of the Record Date, there were 5,046,795 shares of Common Stock issued and outstanding and the Majority Consenting Stockholders held 3,804,935 shares of Common Stock, or 75.39% of the issued and outstanding shares of Common Stock.”

HG Holdings, Inc. shareholders approved Election of one director, Jeffrey S. Gilliam, to serve until the 2029 annual meeting at the 2026-06-15 meeting.

“As of the Record Date, there were 5,046,795 shares of Common Stock issued and outstanding and the Majority Consenting Stockholders held 3,804,935 shares of Common Stock, or 75.39% of the issued and outstanding shares of Common Stock.”

Green Thumb Industries Inc. shareholders approved Setting the number of directors at seven.

“Proposal No. 1: Setting the number of directors of the Company at seven: FOR AGAINST 294,245,458 502,943”

Green Thumb Industries Inc. shareholders approved Amendment of articles to vary automatic conversion provisions of Super Voting Shares.

“Proposal No. 5: The approval of the amendment of the Company’s current articles to vary the automatic conversion provisions of the Super Voting Shares as further described in the Proxy Statement. All votes cast: FOR AGAINST ABSTAIN BROKER NON-VOTES 228,711,228 6,491,284 576,257 58,969,632”

Green Thumb Industries Inc. shareholders approved Appointment of Baker Tilly US, LLP as auditors.

“Proposal No. 4: The appointment of Baker Tilly US, LLP as auditors for the Company and authorization of the Board to fix the auditors’ remuneration and terms of engagement: FOR WITHHOLD 292,810,365 1,938,036”

Green Thumb Industries Inc. shareholders approved Advisory approval of compensation of named executive officers.

“Proposal No. 3: The approval, on an advisory basis, of the compensation paid to the Company’s named executive officers, as disclosed in the Proxy Statement for the meeting: FOR AGAINST ABSTAIN BROKER NON-VOTES 233,451,939 2,089,831 236,999 58,969,632”

Green Thumb Industries Inc. shareholders approved Election of directors.

“Proposal No. 2: Election of directors: FOR WITHHOLD BROKER NON-VOTES Dawn Wilson Barnes 230,390,507 5,388,262 58,969,632 Anthony Georgiadis 229,892,078 5,886,691 58,969,632 Jeffrey Goldman 228,695,482 7,083,287 58,969,632 Benjamin Kovler 229,902,706 5,876,063 58,969,632 Ethan Nadelmann 230,401,238 5,377,531 58,969,632 Richard Reisin 230,379,527 5,399,242 58,969,632 Hannah (Buchan) Ross 230,188,382 5,590,387 58,969,632”

RYTHM, Inc. shareholders approved Approval of Amendment to 2022 Omnibus Equity Incentive Plan to increase share reserve by 115,000 shares at the 2026-06-16 meeting.

“Proposal 3 - Approval of Amendment to 2022 Omnibus Equity Incentive Plan The amendment to the 2022 Plan to increase the number of shares of Common Stock available for issuance thereunder by 115,000 shares was approved.”

RYTHM, Inc. shareholders approved Ratification of Appointment of GuzmanGray as independent registered public accounting firm at the 2026-06-16 meeting.

“Proposal 2 - Ratification of Appointment of GuzmanGray The appointment of GuzmanGray as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.”

RYTHM, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.

“Proposal 1 - Election of Directors Each of the director nominees listed below were elected as directors for a one-year term, such term to continue until the annual meeting of stockholders in 2027 or until such directors’ successors are duly elected and qualified.”

Designer Brands Inc. shareholders approved Make Certain Other Clarifying, Technical and Conforming Changes at the 2026-06-17 meeting.

“Proposal 4f. Make Certain Other Clarifying, Technical and Conforming Changes Votes For Votes Against Abstentions Broker Non-Votes 89,632,879 87,890 38,558 7,890,356”

Designer Brands Inc. shareholders approved Authorize the Company's Board of Directors to Amend the Code to the Extent Permitted by Ohio Law at the 2026-06-17 meeting.

“Proposal 4e. Authorize the Company's Board of Directors to Amend the Code to the Extent Permitted by Ohio Law Votes For Votes Against Abstentions Broker Non-Votes 83,137,064 6,579,293 42,970 7,890,356”

Designer Brands Inc. shareholders approved Amend the Provisions Relating to Director and Officer Indemnification and Related Matters at the 2026-06-17 meeting.

“Proposal 4d. Amend the Provisions Relating to Director and Officer Indemnification and Related Matters Votes For Votes Against Abstentions Broker Non-Votes 75,248,334 14,460,673 50,320 7,890,356”

Designer Brands Inc. shareholders approved Expressly Permit the Issuance of Uncertificated Shares at the 2026-06-17 meeting.

“Proposal 4c. Expressly Permit the Issuance of Uncertificated Shares Votes For Votes Against Abstentions Broker Non-Votes 89,633,609 102,845 22,873 7,890,356”

Designer Brands Inc. shareholders approved Modify the Voting Standard for Approval of Matters Other Than the Election of Directors at the 2026-06-17 meeting.

“Proposal 4b. Modify the Voting Standard for Approval of Matters Other Than the Election of Directors Votes For Votes Against Abstentions Broker Non-Votes 89,657,142 67,134 35,051 7,890,356”

Designer Brands Inc. shareholders approved Revise and Enhance the Company's Advance Notice Procedures at the 2026-06-17 meeting.

“Proposal 4a. Revise and Enhance the Company's Advance Notice Procedures Votes For Votes Against Abstentions Broker Non-Votes 84,126,212 5,606,572 26,543 7,890,356”

Designer Brands Inc. shareholders approved Advisory Approval of Named Executive Officer Fiscal 2025 Compensation at the 2026-06-17 meeting.

“Proposal 3: Advisory Approval of Named Executive Officer Fiscal 2025 Compensation Voting results regarding the approval of the non-binding, advisory vote on the fiscal 2025 compensation of the Company’s named executive officers as reported in the Proxy Statement were as follows: Votes For Votes Against Abstentions Broker Non-Votes 87,243,495 2,346,086 169,746 7,890,356”

Designer Brands Inc. shareholders approved Ratification of Appointment of Deloitte & Touche LLP at the 2026-06-17 meeting.

“Proposal 2: Ratification of Appointment of Deloitte & Touche LLP Voting results regarding the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 30, 2027 were as follows: Votes For Votes Against Abstentions Broker Non-Votes 97,258,468 384,602 6,613 —”

Designer Brands Inc. shareholders approved Election of Four Class I Director Nominees at the 2026-06-17 meeting.

“Proposal 1: Election of Four Class I Director Nominees Voting results regarding the election of four Class I director nominees were as follows: Name of Nominee Votes For Votes Withheld Broker Non-Votes Harvey L. Sonnenberg 88,887,051 872,276 7,890,356 Allan J. Tanenbaum 81,988,253 7,771,074 7,890,356 Peter S. Cobb 80,813,651 8,945,676 7,890,356 Douglas M. Howe 89,638,219 121,108 7,890,356”